πŸ‡ΊπŸ‡Έ FDA
Patent

US 8258106

Immunostimulatory nucleic acid molecules

granted A61KA61K2039/55561A61K31/00

Quick answer

US patent 8258106 (Immunostimulatory nucleic acid molecules) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/55561, A61K31/00, A61K31/4706, A61K31/7048